{
    "clinical_study": {
        "@rank": "117726", 
        "arm_group": [
            {
                "arm_group_label": "Midazolam", 
                "arm_group_type": "Active Comparator", 
                "description": "Administered as a single oral 6 mg dose on Day 1."
            }, 
            {
                "arm_group_label": "SSP-004184SS + Midazolam", 
                "arm_group_type": "Experimental", 
                "description": "Midazolam (6 mg) + SSP-004184SS (30 mg/kg) concomitantly administered as a single oral dose on Day 1."
            }
        ], 
        "brief_summary": {
            "textblock": "A Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 and Midazolam in\n      Healthy Adult Subjects"
        }, 
        "brief_title": "Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Normal healthy male and female volunteers between the ages of 18 and 65, inclusive\n\n          -  Serum ferritin, hemoglobin and erythrocyte indices within normal range\n\n        Exclusion Criteria:\n\n          -  Evidence of any active or chronic disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01989169", 
            "org_study_id": "SPD602-117"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Midazolam", 
                    "SSP-004184SS + Midazolam"
                ], 
                "intervention_name": "Midazolam", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "SSP-004184SS + Midazolam", 
                "intervention_name": "SSP-004184SS", 
                "intervention_type": "Drug", 
                "other_name": "SPD602"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Midazolam"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "January 8, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Miami", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "33014"
                }, 
                "name": "Clinical Pharmacology of Miami, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 1, Randomized, Open Label, Crossover Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects", 
        "overall_official": {
            "affiliation": "Clinical Pharmacology of Miami, Inc.", 
            "last_name": "Kenneth C Lasseter, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Area Under the Plasma Concentration-time Curve (AUC) of Midazolam", 
                "safety_issue": "No", 
                "time_frame": "Over 72 hours post-dose"
            }, 
            {
                "measure": "Maximum Plasma Concentration (Cmax) of Midazolam", 
                "safety_issue": "No", 
                "time_frame": "Over 72 hours post-dose"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01989169"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Shire", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shire", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}